Agilent Launches Agilent Advanced Therapeutics

Live From Show Updates

Cambrex Advances U.S. and European Expansions

Charles City expansion will add a new API plant with 140,000 liters of capacity.

SPONSOR

Streamline HME Projects with Early Partner Engagement

Hot-melt extrusion (HME) is an advantageous method for enhancing the solubility and bioavailability of poorly soluble active pharmaceutical ingredients (APIs) — if the formulation is robust and scalable. Partnering early on with an experienced CDMO can help accelerate the development of optimal, scalable, and patient-centric HME products.

Live From Show Updates

IPP Offers Access to API Manufacturing Capacity at Grimsby, UK Site

Qualified companies can use one or more of three established pharmaceutical manufacturing plants on the campus under a flexible commercial structure.

Live From Show Updates

Esteve CDMO to Add New Production Unit in Celrà

New 3,000-square-meter production unit to accommodate additional spray drying equipment and services in purpose-built, high-potency containment suites.

SPONSOR

Celebrate Ropack’s 50th with Cocktails at The CDMOLAs

Ready for cocktails? Join us as Ropack celebrates 50 years of success with specialty cocktails at The Pool in NYC tomorrow, March 25th. Doors open at 6pm. Register in advance!

Live From Show Updates

Kindeva Commemorates 70 years of the pMDI 

Kindeva alumni George Maison, Irving Porush and Charles Thiel to be inducted into the ‘National Inventors Hall of Fame’.

Live From Show Updates

Lonza, Genetix Bio Extend Commercial Mfg. Pact for ZYNTEGLO

Will expand manufacturing capacity at Lonza’s Houston facility to support growing demand for Genetix’s ZYNTEGLO.

SPONSOR

Meet the makers of more tomorrows at DCAT Week

Discover how Kindeva helps bring life-changing therapies to patients faster. Meet us March 23–26.

SPONSOR

Bring us your batch. We’ll deliver.

Complex molecule? Difficult process? We’re your people. We’ve got a decades-long history of problem solving and fear-no-challenge culture.

SPONSOR

Ahead of DCAT Week, IPP Offers Unique Capital-Light Route into World-Class API Manufacturing Capacity

International Process Plants (IPP) announces a direct path into commercial volume small molecule API manufacturing for pharmaceutical & CDMO companies at its Grimsby, UK platform—without the capital burden of acquisition or greenfield buildout.